Pacific Biosciences
PACB
PACB
99 hedge funds and large institutions have $331M invested in Pacific Biosciences in 2018 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 38 increasing their positions, 26 reducing their positions, and 10 closing their positions.
Holders
99
Holders Change
-2
Holders Change %
-1.98%
% of All Funds
2.27%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
8
Increased
38
Reduced
26
Closed
10
Calls
$182K
Puts
$495K
Net Calls
-$313K
Net Calls Change
+$39K
Top Buyers
| 1 |
AIM
1
ARK Investment Management
St. Petersburg,
Florida
|
$22.4M |
| 2 |
BC
2
Broadfin Capital
New York
|
$3.74M |
| 3 |
3
BlackRock
New York
|
$34.2M |
| 4 |
4
Point72 Asset Management
Stamford,
Connecticut
|
$10.3M |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$21.1M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
101
Walleye Trading
New York
| – | -$135K | -66,000 | Closed |
|
102
SG Americas Securities
New York
| – | -$58K | -28,103 | Closed |
|
|
VF
103
Virtu Financial
New York
| – | -$50K | -24,424 | Closed |
|
|
TRCT
104
Tower Research Capital (TRC)
New York
| – | -$43K | -20,841 | Closed |
|
105
Balyasny Asset Management
Chicago,
Illinois
| – | -$41K | -19,958 | Closed |
|
106
Parallax Volatility Advisers
San Francisco,
California
| – | -$24K | -11,896 | Closed |
|
|
PHK
107
Point72 Hong Kong
Hong Kong
| – | -$2K | -1,127 | Closed |
|